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+ 15 93.8 19 57.6 0.01
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- 3 18.7 25 75.8  
Pleural tag 
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- 13 81.3 23 69.7  
 
PD1-2-8 EUS and PET-CT in Lung Cancer Staging, Mon, 16:00 - 17:30
The role of PET-CT results in evaluating the aggressiveness of 
small solid lung cancers
Shiono, Satoshi; Sato, Toru 
Department of Thoracic Surgery, Yamagata Prefectural Central Hospi-
tal, Yamagata, Japan
Background: Positron emission tomography (PET) ﬁndings can be 
used to predict survival after surgical resectioning for lung cancer, as 
the results of the PET scan might be correlated with pathological ﬁnd-
ings. Although small lung cancers with ground-glass attenuation have 
a favorable prognosis, CT evaluations of tumor aggressiveness in solid 
lung cancer may be difﬁcult to carry out. Additionally, indications for 
limited resection for solid small lung cancers are controversial. This 
study was conducted to evaluate the relationship between PET-CT 
results and pathological ﬁndings in solid lung cancer cases where the 
tumors are ≤ 3 cm in size. 
Methods: From June 2004 through December 2006, 81 clinical stage 
IA patients underwent lung cancer resections. Lung nodules were clas-
siﬁed as solid or non-solid according to their CT ﬁndings. From this 
group, we reviewed the histories of 53 patients (65%) who had lung 
cancer with a solid tumor ≤ 3 cm in size, lymph node dissection and a 
preoperative PET-CT scan. Their ages ranged from 32 to 81, with an 
average of 65 years. There were 26 men and 27 women. The surgical 
procedures performed were lobectomy in 52 cases (98%) and segmen-
tectomy in 1 (2%). Patients with non-solid nodules or who underwent 
wedge resections were excluded. Four patients (8%) received adjuvant 
chemotherapy after surgery. In their pathological ﬁndings, lung cancers 
that exhibited nodal, lymphovascular or pleural invasion were deﬁned 
as invasive lung cancers. We analyzed the association between the 
pathological ﬁndings and the following preoperative clinical factors: 
age, sex, smoking history (+ or -), CEA ≤ 5.0 or > 5.0 ng/ml, tumor size 
and max SUV values. 
Results: The pathological diagnoses were as follows: 45 (85%) adeno-
carcinomas, 5 (10%) squamous cell carcinoma, 1 (2%) adenosquamous 
carcinoma, 1 (2%) atypical carcinoid, and 1 (2%) small cell carcinoma. 
There were 15 (28%) invasive lung cancer cases. Multivariate analysis 
showed tumor size (P=0.02) and max SUV (P=0.003) to be indepen-
dent predictive factors of invasive lung cancer. The proportion of 
patients with a max SUV value greater than 3.0 was signiﬁcantly higher 
in invasive lung cancer cases. When the threshold value of max SUV 
was set at 3.0, the sensitivity for predicting an invasive lung cancer in 
solid lung nodules was 93% (14/15), with a speciﬁcity of 42% (16/38). 
The positive predictive value was 39% (14/36) and the negative predic-
tive value was 94% (16/17). In the follow-up, 3 of 53 (6%) patients 
experienced a recurrence of the cancer within two years, and the preop-
erative max SUV value of all of these patients was greater than 8.0. 
Conclusions: We found that PET-CT results were correlated with 
pathological severity in small solid lung cancers. In the preoperative 
assessment, solid lung cancers with high max SUV values were recom-
mended for a standard resection.
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Endobronchial treatment in general anesthesia with jet ventilation 
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Background: The aim of our study is to evaluate the complications 
developing during or after the endobronchial electrosurgary and laser 
brocnhsocopy in general anesthesia with jet ventilation and investigate 
the safety of this procedures.
Methods: In this study from the years 2002-2006 158 patients under-
went 217 endobronchial therapeutic procedures. All procedures were 
performed in general anesthesia with jet ventilantion though rigid 
bronchoscope. We wedged videobronchoscop through rigid broncho-
scope. According The American Society of Anesthesiologists´(ASA) 
physical classiﬁcation were 55% patients ASA III and 45% ASA IV. 
The therapeutic endobronchial procedure was done in 129 patinets 
with endobronchial NSCLC, in 12 patients with endobronchial SCLC, 
in 6 patients with endobronchial metastases of melanoma, in 3 with 
endobronchial metastasis of renal carcinoma, in 7 patients we started 
with endobronchial treatment before the morphological diagnosis. We 
started with the endobronchiasl treatment because of dyspnea in100% 
patients (in 55% patients was dyspnea at rest), in 57 %patients was 
cough, in 12% hemoptysis, in 2% pneumonia. During and after proce-
dure we controlled oxymetry, electrocardiography, blood pressure.
Copyright © 2007 by the International Association for the Study of Lung Cancer S421
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Results: During and after procedures we observed in 28% patients 
hypoxemia, in 23 % hemorrhage 250 cm3 and more, in 10% arytmias, 
in 5% patients we observed hypertension and in 2% patients developed 
after procedure respiratory failure and both patients were 24 hours 
on invasive ventilation. Two patients died due complications after 
procedure. Any complications we observed in 40% of all procedures. 
The procedure leads to improvement of symptoms in 80% patients. 
The difference in number of complications in patients with ASA III and 
with ASA IV was not statistically signiﬁcant (p=0.009).
Conclusions: Endobronchial treatment (electrosurgary and laser 
brochoscopy) leads to improvement of symptoms in 80% patients. 
This treatment procedure in general anesthesia with jet ventilation is 
therapeutic procedure with acceptable rate of complications in patients 
with endobronchial growth of malignancies and in patients with ASA 
classiﬁcation III and IV.
PD1-3-2 Pathology and Bronchoscopy, Mon, 16:00 - 17:30
Flexible bronchoscopy in lung cancer
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Background: Bronchoscopy is usually performed under topical anes-
thesia with or without sedation to promote patient comfort and the ideal 
conditions for the physician to perform the examination. The objective 
of the study was to establish which anesthetic procedure used during 
ﬂexible bronchoscopy for lung cancer diagnostic has the lowest index 
of complications. 
Methods: This prospective randomized study analyzed 80 patients that 
underwent ﬂexible bronchoscopy for lung cancer diagnostic. Patients 
were randomly assigned to four groups of 20 patients each according 
to the anesthetic combination used: 200 mg topical lidocaine (LID 
group); 200 mg topical lidocaine and 2 mg/kg propofol (PPF group); 
200 mg topical lidocaine and 20 mcg/kg alfentanil (ALF group); or 200 
mg topical lidocaine and 0.05 mg/kg midazolam (MID group). Scores 
were assigned to patients according to the different variables observed 
during the bronchoscopic procedure; the lower the score, the lower the 
complication index. 
Results: Results of the composite score (mean and standard devia-
tion) for the evaluation of the variables observed during ﬂexible 
bronchoscopy were 4.6„b3.9 for the PPF group, 7.9„b6.6 for the ALF 
group, 10.0„b4.5 for the LID group, and 11.3„b5.8 for the MID group 
(p=0.001).
Conclusions: Results showed that the combination of propofol and 
topical lidocaine was a superior anesthetic method for ﬂexible bron-
choscopy than lidocaine alone or in association with midazolam or 
alfentanil.
Clinical Implications: The choice of an effective and low morbidity 
anesthetic method is basic for the success of a diagnostic ﬂexible bron-
choscopy. This study it demonstrated the superiority of the association 
of propofol and topic lidocaine in the anesthesia for ﬂexible bronchos-
copy in lung cancer patients.
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Estrogen receptor overexpression in non-small cell lung cancer is 
associated with better survival in males.
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Background: Adenocarcinoma of the lung is more frequent in females 
than in males and the association with smoking is less pronounced than 
for the other histological subtypes of lung cancer. Thus other factors 
than smoking may be involved in the carcinogenesis of lung cancer. 
Estrogen induction of cellproliferation has been found in for example 
breast adenocarcinoma and since estrogen receptors (ER) have been 
demonstrated in lung tumours, a similar role of estrogens in the devel-
opment of lung cancer has been suggested. 
Whereas ERalfa plays a key role in adenocarcinomas of the breast, sev-
eral studies indicate a more predominant role of ERbeta in lung cancer. 
We examined the expression of ERalfa, ERbeta, and Progesterone in a 
well deﬁned Danish cohort of patients with NSCLC with more than 15 
years of follow up, and related the results to gender and survival. 
Methods: Parafﬁn embedded, histological material was collected from 
104 patients (71 men and 33 women), operated in the period 1989-1992 
for NSCLC (56 squamous cell carcinomas, 40 adenocarcinomas and 8 
large cell carcinomas). Sixtythree patients were in stage I, 14 patients 
in stage II, 24 patients in stage IIIA, and 3 patients in stage IIIB.
ERalfa (clone 1D5, DAKO), ERbeta (clone PPG5/10, DAKO) and Pro-
gesterone (clone PgR 636, DAKO) were immunohistochemically ana-
lyzed. Staining frequency and intensity was scored semiquantitatively. 
A tumour was deﬁned as positive when more than 10% of the tumour 
cells were positive with at least a weak nuclear staining. Kaplan-Meier 
survival curves were generated to evaluate the signiﬁcance of ERalfa, 
ERbeta and Progesterone expression for the prognosis. 
Results: ERbeta positivity was demonstrated in 69% (72 of 104) of the 
tumours. There was no statistically signiﬁcant correlation between ER-
beta positivity and age, sex, stage, or histology. After adjusting for sex, 
age, stage at diagnosis and histology there was no difference in survival 
between subjects with ERbeta-positive and ERbeta-negative tumours. 
Analysis was repeated after stratifying by sex. Women with ERbeta-
negative tumours had a non-signiﬁcant (p=0.26) decrease in mortality 
compared with women with ERbeta positive tumours. In contrast, men 
with ERbeta positive tumours had a reduced mortality (p=0.03) com-
pared to men with ERbeta negative tumours (see Figure). 
